Consumer
Gee Mathen, director of pharmacy clinical applications and technical services at Texas Children's Hospital, discusses his upcoming HIMSS24 session "Combating Counterfeit Drugs and the Drug Supply Chain Security Act."
The software company is launching its new AI-powered healthcare product that uses health organization's data to personalize patient care to reduce administrative tasks.
New financing positions BrainCheck for growth as the company adds a new member to its board of directors.
The food delivery company's engagement program will focus on providing nutritious food and tailored educational content to expectant and new mothers.
HIMSS24
Cleveland Clinic ACO's Dr. Jessica Hohman and Cleveland Clinic Florida's Dr. Richard Rothman discuss their upcoming HIMSS24 session on how the hospital system created and evolved its scalable home-based acute and post-acute care models.
The virtual care company reported a 65% increase in revenue in 2023 compared to 2022 and a 47% increase in Q4 2023 revenue compared to the previous year.
Dr. Sashi Moodley, chief medical officer at Walgreens, discusses the reasoning behind the pharmacy store chain's recently announced closures of VillageMD clinics.
HIMSS24
Chief information officers Cris Ross and Ed Marx discuss their book to be released in the fall, the role of technology in the patient experience, their personal health experiences and the white paper slated to be released at HIMSS24.
The company will use the funds to create and launch new products, expand its network and speed up its growth.
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, discusses how Froedtert and Inception Health use genAI, including helping patients with scheduling and navigating healthcare.